Notal Vision

Notal Vision

Hospitals and Health Care

Manassas, VA 5,241 followers

A digital healthcare provider offering remote monitoring services to support physicians' AMD patient care

About us

Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.

Industry
Hospitals and Health Care
Company size
51-200 employees
Headquarters
Manassas, VA
Type
Privately Held
Founded
2000
Specialties
AMD, Dry AMD, Macular Degeneration, Telemedicine, wet AMD, Teleheath, Optometry, Ophthalmology, Digital Healthcare, remote monitoring, retina, artificial intelligence, diabetic macular edema, nAMD, monitoring center, age related macular degeneration, neovascular macular degeneration, teleoptometry, and teleophthalmology

Locations

Employees at Notal Vision

Updates

Similar pages

Browse jobs

Funding

Notal Vision 3 total rounds

Last Round

Series D

US$ 60.0M

See more info on crunchbase